DMD and muscular dystrophy: We have previously shown, in mdx mice with muscular dystrophy (dystrophin-deficient), that rapamycin-loaded PFC nanoparticles can be trapped in damaged and inflamed muscle and heart tissues after IV administration, where they serve as a depot for the slow and sustained release of the drug in high local quantities, which can improve muscular strength in part by limiting autophagy [38].